The French pharmaceutical company, Cristers, has selected Adents Prodigi to ensure compliance with the EU Falsified Medicines Directive (FMD) and provide beyond-compliance ROI.
Cristers markets generic and OTC products, and is a French lab owned by a cooperative of pharmacists. Holding a marketing authorization for more than 400 products, Cristers differentiates itself with clear and easy-to-use packaging to facilitate communication with patients.
While searching for a serialization system that would ensure compliance with the FMD, Cristers also sought a means of enabling easy exchange of serialization data with its supply chain partners, including contract manufacturers and logistics providers. Additionally, Cristers wanted a solution that would aid in the onboarding of more than 30 European partners – including CMOs, vendors and third-party logistics providers – and facilitate connection with a diverse set of Levels 3 and 4 serialization solutions.
Jointly developed with Microsoft and powered by Azure, Adents Prodigi allows for secure data exchange and helps leverage serialization data to improve business practices. The systems are designed to help companies gain simplified speed to compliance with regulatory requirements.
Prodigi centrally manages regulatory requirements for Cristers and provides an easy onboarding process to connect multiple trading partners.
“Adents Prodigi solution was the best native cloud Level 4 solution that offers us scalable and cost-efficient IT architecture in addition to a quick and easy partners on-boarding,” said Hervé Abou, Head Pharmacist of Cristers.